Bioxyne Signs $50m Exclusive German Supply Deal with ADREX
Bioxyne lands $50m exclusive German supply deal with ADREXpharma, securing $25m minimum in first year, boosting Europe revenue visibility and...
News
Here, we share stories about our research, innovations in biotechnology, partnerships, and the people behind our mission to support better health from within. Stay informed, stay inspired, and explore how BLS Pharmaceuticals Ltd continues to advance science for a healthier tomorrow.
Bioxyne lands first Costa Rica flower supply deal
Bioxyne subsidiary Breathe Life Sciences (BLS) has signed its first medicinal cannabis flower supply agreement in Costa Rica. The deal...
BREATHE LIFE SCIENCES | A BREATH OF FRESH AIR
Bioxyne partners with Aurora Cannabis
Australian Bioxyne Limited has signed a manufacturing agreement with global medical cannabis company Aurora Cannabis Inc., marking a significant step...
Manufacturing deal signed between Bioxyne and Aurora Cannabis for medicinal products
Bioxyne Limited has announced a new manufacturing agreement with Aurora Cannabis Inc., placing manufacturing at the center of a partnership...
Vantage Point Podcast: Delivering medicines for treatment resistant patients with unmet needs
In the latest episode of Vantage Point Podcast, I sat down with Sam Watson, MD of Bioxyne (BXN:ASX), to unpack...
Vantage Point Podcast: Inside Bioxyne: The ASX’s Profitable Play on Medicinal Cannabis, MDMA & Psilocybin
In this episode, we sit down with Sam Watson, managing director of Bioxyne (BXN:ASX), to unpack how the company is...
ASX Briefs: How GMP MDMA and Psilocybin are reshaping access for treatment-resistant patients
Podcast: ASX Briefs – Sam Watson Interview A 149% revenue surge, first‑to‑market GMP MDMA in Australia, and a plan to...